Inventor · disambiguated record
William Frietze
Also filed as: FRIETZE WILLIAM · FRIETZE WILLIAM E · FRIETZE WILLIAM ERIC
19 granted patents·14 pending applications·226 citations·filing 1997–2024
95Inventor score
Files withINCYTE CORP13ASTRAZENECA AB6BRISTOL MYERS SQUIBB PHARMA CO3DU PONT PHARM CO3BALESTRA MICHAEL2
Top patents by PatentIndex Score
33 records- 0198US11066394B2Solid forms of an HPK1 inhibitorINCYTE CORP·Filed 2020·Granted Jul 20, 2021·12 cites·44 claims
- 0297US10858372B2Amorphous solid form of a BET protein inhibitorINCYTE CORP·Filed 2019·Granted Dec 8, 2020·10 cites·14 claims
- 0396US10329305B2Amorphous solid form of a BET protein inhibitorINCYTE CORP·Filed 2018·Granted Jun 25, 2019·16 cites·19 claims
- 0495US6589958B1Isoxazolo [4,5-d] pyrimidines as CRF antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Jul 8, 2003·78 cites·4 claims
- 0593US11787784B2Solid forms of an HPK1 inhibitorINCYTE CORP·Filed 2021·Granted Oct 17, 2023·2 cites·26 claims
- 0692US9321755B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2014·Granted Apr 26, 2016·15 cites·66 claims
- 0789US12024522B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2021·Granted Jul 2, 2024·1 cites·48 claims
- 0886US6579876B2Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Jun 17, 2003·12 cites·6 claims
- 0985US10280157B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2017·Granted May 7, 2019·3 cites·12 claims
- 1081US9873688B2Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitorINCYTE CORP·Filed 2016·Granted Jan 23, 2018·2 cites·6 claims
- 1181US2023219976A1Amorphous solid form of a bet protein inhibitorINCYTE CORP·Filed 2023·Application pending·0 cites
- 1280US8013165B2Ethanamine compounds and methods of using the same 545ASTRAZENECA AB·Filed 2009·Granted Sep 6, 2011·3 cites·2 claims
- 1380US2025129079A1Salts and processes of preparing a pi3k inhibitorINCYTE CORP·Filed 2024·Application pending·0 cites
- 1478US6521636B1Imidazo-pyridines as corticotropin releasing factor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Feb 18, 2003·6 cites·3 claims
- 1578US6159980APyrazinones and triazinones and their derivatives thereofDU PONT PHARM CO·Filed 1997·Granted Dec 12, 2000·42 cites·28 claims
- 1678US2024425506A1Solid forms of an fgfr inhibitor and processes for preparing the sameINCYTE CORP·Filed 2024·Application pending·0 cites
- 1772US2021079016A1Amorphous solid form of a bet protein inhibitorINCYTE CORP·Filed 2020·Application pending·0 cites
- 1868US6294671B1Isoxazolo[4, 5-D]pyrimidines as CRF antagonistsDU PONT PHARM CO·Filed 1999·Granted Sep 25, 2001·10 cites·13 claims
- 1960US9035065B2Ethanamine compounds and methods of using the sameASTRAZENECA AB·Filed 2013·Granted May 19, 2015·0 cites·12 claims
- 2058US6509338B1Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonistsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jan 21, 2003·7 cites·15 claims
- 2158US2017121347A1Amorphous solid form of a bet protein inhibitorINCYTE CORP·Filed 2016·Application pending·0 cites
- 2253US2004023965A1Imidazo-triazines as corticotropin releasing factor antagonistsFiled 2003·Application pending·0 cites
- 2351US6218391B1Triazinones and derivatives thereofDU PONT PHARM CO·Filed 1999·Granted Apr 17, 2001·4 cites·24 claims
- 2449US2012277272A1Ethanamine Compounds and Methods of Using the SameBALESTRA MICHAEL·Filed 2012·Application pending·0 cites
- 2548US2012115913A1Ethanamine Compounds and Methods of Using the SameBALESTRA MICHAEL·Filed 2011·Application pending·0 cites
- 2647US6365589B1Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Apr 2, 2002·2 cites·4 claims
- 2747US2007249588A1Nicotinic Acetylcholine Receptor LigandsASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2847US2007244097A1Nicotinic AcetylcholineReceptor LigandsASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2947US2002013461A1Isoxazolo [4,5-d] pyrimidines as CRF antagonistsFiled 2001·Application pending·0 cites
- 3042US2008081833A1Novel Pyrazole Derivatives And Their Use As Modulators Of Nicotinic Acetylcholine ReceptorsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 3139US2009012127A1Thiophene-2-Carboxamide Derivatives as Alpha 7 Nicotinic Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3237US6348504B1Oxime ethers as IIb/IIa antagonistsFiled 1999·Granted Feb 19, 2002·1 cites·12 claims
- 3331US2012094995A12-aza-bicyclo[2.2.1]heptane compounds and uses thereofALBERT JEFFREY SCOTT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Frietze files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →